Tag: Novo Nordisk

Browse all articles tagged with “Novo Nordisk”.

1 article

Cagrilintide: The Long-Acting Amylin Analog Behind CagriSema

A research overview of cagrilintide, Novo Nordisk's investigational long-acting amylin analog designed for weekly dosing and studied in combination with semaglutide as CagriSema for enhanced weight management.

2026-01-30·10 min read

CagrilintideamylinCagriSemasemaglutideNovo Nordiskweight managementmetabolic health

←Back to blog

For informational purposes only. Not medical advice. Always consult with qualified healthcare professionals.